Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Thomas

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Blood|January 9, 2007
Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemiaElias Jabbour, Susan O'Brien, Hagop Kantarjian, et al.
Cancer|March 3, 2011
Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitorsJesse Jaso, Deborah A Thomas, Krista Cunningham, et al.
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase I study of oral topotecan in hematological malignanciesMiloslav Beran, Susan O'Brien, Deborah A Thomas, et al.
Blood|June 21, 2003
Rituximab in relapsed or refractory hairy cell leukemiaDeborah A Thomas, Susan O'Brien, Carlos Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Dynamic model for predicting death within 12 months in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosisConstantine S Tam, Hagop Kantarjian, Jorge Cortes, et al.
Cancer Medicine|December 10, 2014
A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer CenterKhanh Vu, Nhiem V Luong, Julie Hubbard, et al.
Cancer|April 2, 2011
Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemiaSergej Konoplev, Jeffrey L Jorgensen, Deborah A Thomas, et al.
Current Hematologic Malignancy Reports|December 31, 2010
Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?Deborah A Thomas, Susan O'Brien, Stefan Faderl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2014
ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjectsScott L Letendre, Anthony M Mills, Karen T Tashima, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Blood|January 9, 2007
Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemiaElias Jabbour, Susan O'Brien, Hagop Kantarjian, et al.
Cancer|March 3, 2011
Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitorsJesse Jaso, Deborah A Thomas, Krista Cunningham, et al.
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase I study of oral topotecan in hematological malignanciesMiloslav Beran, Susan O'Brien, Deborah A Thomas, et al.
Blood|June 21, 2003
Rituximab in relapsed or refractory hairy cell leukemiaDeborah A Thomas, Susan O'Brien, Carlos Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Dynamic model for predicting death within 12 months in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosisConstantine S Tam, Hagop Kantarjian, Jorge Cortes, et al.
Cancer Medicine|December 10, 2014
A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer CenterKhanh Vu, Nhiem V Luong, Julie Hubbard, et al.
Cancer|April 2, 2011
Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemiaSergej Konoplev, Jeffrey L Jorgensen, Deborah A Thomas, et al.
Current Hematologic Malignancy Reports|December 31, 2010
Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?Deborah A Thomas, Susan O'Brien, Stefan Faderl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2014
ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjectsScott L Letendre, Anthony M Mills, Karen T Tashima, et al.
Pageof 11